Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks

C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

NCT01397864 ·Status: COMPLETED

A Study of Lanadelumab in Teenagers and Adults With Hereditary Angioedema (HAE) in the Kingdom of Saudi Arabia

NCT07263685 ·Status: RECRUITING

Renal Impairment Study of PF-06700841

NCT04260464 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II

NCT05055258 ·Status: TERMINATED ·Phase: PHASE2

Safety and Pharmacokinetics of GEH200486 in Healthy Volunteers

NCT05569278 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function

NCT07315360 ·Status: RECRUITING ·Phase: PHASE1

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

NCT02646358 ·Status: COMPLETED ·Phase: PHASE1

Vonafexor in Patients With Impaired Renal Function and Suspected MASH (Metabolic Dysfunction-associated Steatohepatitis)

NCT06939816 ·Status: TERMINATED ·Phase: PHASE2

Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis

NCT03289520 ·Status: COMPLETED ·Phase: PHASE3

An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

NCT05505916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of WAL0921 in Patients With Glomerular Kidney Diseases

NCT06466135 ·Status: RECRUITING ·Phase: PHASE2

Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency

NCT02870309 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Renal Impairment Study for PF-04965842

NCT03660241 ·Status: COMPLETED ·Phase: PHASE1

Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy

NCT07289763 ·Status: RECRUITING ·Phase: PHASE2

PK Study of ACHN-490 Injection in Renally Impaired Subjects

NCT01462136 ·Status: COMPLETED ·Phase: PHASE1

HENOX: Enoxaparine in Hemodialysis

NCT00347490 ·Status: COMPLETED ·Phase: PHASE4

Prevention of Vascular Access Graft Failure in Patients With Chronic Renal Failure Requiring Hemodialysis

NCT00086164 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Berinert (C1INH) vs Placebo for DGF/IRI

NCT04696146 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study on Efficacy and Safety of LNP023 in C3 Glomerulopathy Patients Transplanted and Not Transplanted

NCT03832114 ·Status: COMPLETED ·Phase: PHASE2

Study of the Influence of Liver Function on Blood Concentrations of Runcaciguat in Participants With Different Degrees of Liver Impairment

NCT04820621 ·Status: TERMINATED ·Phase: PHASE1

Study to Assess the Effect of Renal Impairment on the Pharmacokinetics of CTP-543

NCT05468749 ·Status: COMPLETED ·Phase: PHASE1

Anemia Study in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Blood Pressure (ASCEND-BP)

NCT03029247 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria

NCT05457283 ·Status: RECRUITING ·Phase: PHASE3

A Study of LY3113593 in Participants With Chronic Kidney Disease

NCT02604160 ·Status: COMPLETED ·Phase: PHASE1

Safety and Efficacy Assessment of HAV in Patients Needing Vascular Access for Dialysis

NCT04135417 ·Status: COMPLETED ·Phase: PHASE2